ClinVar Miner

Submissions for variant NM_000138.5(FBN1):c.3978T>G (p.Cys1326Trp)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Clinical Genomics Laboratory, Washington University in St. Louis RCV005052309 SCV005685491 likely pathogenic Marfan syndrome 2024-07-10 criteria provided, single submitter clinical testing A FBN1 c.3978T>G (p.Cys1326Trp) variant, to our knowledge, has not been reported in the medical literature. This variant is absent from the general population (gnomAD v.2.1.1), indicating it is not a common variant. This variant affects cysteine residue within the epidermal growth factor (EGF)-like domain of FBN1 that is defined as a critical functional domain (Collod-Béroud G et al., PMID: 12938084; Schrijver I et al., PMID: 10486319). Computational predictors indicate that the variant is damaging, evidence that correlates with impact to FBN1 function. Another variants in the same codon, c.3977G>A (p.Cys1326Tyr) and c.3976T>C (p.Cys1326Arg), have been reported as likely pathogenic and pathogenic, respectively (ClinVar Variation IDs: 432123 and 2137695). Based on available information and the ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868) and gene-specific practices from the ClinGen Criteria Specification Registry, this variant is classified as likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.